Author Title [ Type(Asc)] Year
Filters: First Letter Of Title is O  [Clear All Filters]
Journal Article
Ruan, Y.-S., Wu, X.-D., Feng, X.-Q., He, Y.-L., Zhang, Y.-M., Pei, F.-Y., and Li, C.-F. (2015). [Outcome of childhood high-risk acute lymphoblastic leukemia treated with the ALL-BFM 95 protocol].Zhongguo Dang Dai Er Ke Za Zhi17, 327-331.
Franssen, L.E., Raymakers, R.A.P., Buijs, A., Schmitz, M.F., van Dorp, S., Mutis, T., Lokhorst, H.M., and van de Donk, N.W.C.J. (2016). Outcome of allogeneic transplantation in newly diagnosed and relapsed/refractory multiple myeloma: long-term follow-up in a single institution.Eur J Haematol.
Pohlen, M., Groth, C., Sauer, T., Görlich, D., Mesters, R., Schliemann, C., Lenz, G., Müller-Tidow, C., Büchner, T., Berdel, W.E., et al. (2016). Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (⩾60 years).Bone Marrow Transplant.
Candoni, A., Rambaldi, A., Fanin, R., Velardi, A., Arcese, W., Ciceri, F., Lazzarotto, D., Lussana, F., Olivieri, J., Grillo, G., et al. (2019). Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Societ.Biol Blood Marrow Transplant.
Ringdén, O., Boumendil, A., Labopin, M., Canaani, J., Beelen, D., Ehninger, G., Niederwieser, D., Finke, J., Stelljes, M., Gerbitz, A., et al. (2019). OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OVER 69 YEARS OF AGE WITH ACUTE MYELOID LEUKEMIA: ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT.Biol Blood Marrow Transplant.
Yoon, J.-H., Kim, H.-J., Jeon, Y.-W., Lee, S.-E., Cho, B.-S., Eom, K.-S., Kim, Y.-J., Lee, S., Min, C.-K., Cho, S.-G., et al. (2015). Outcome of allogeneic hematopoietic stem cell transplantation for cytogenetically normal AML and identification of high-risk subgroup using WT1 expression in association with NPM1 and FLT3-ITD mutations.Genes Chromosomes Cancer.
Hu, M., Wang, H., Wang, L., Yang, M., Lou, Y., and Jin, J. (2018). Outcome of adult T-lymphoblastic lymphoma depends on ALL-type chemotherapy, prognostic factors, and performance of allogeneic hematopoietic stem cell transplantation.Medicine (Baltimore)97, e11374.
Kobayashi, R., Mitsui, T., Fujita, N., Osumi, T., Aoki, T., Aoki, K., Suzuki, R., Fukuda, T., Miyamoto, T., Kato, K., et al. (2016). Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation.Int J Hematol.
Yun, S., Vincelette, N.D., Abraham, I., Puvvada, S., and Anwer, F. (2016). Outcome Comparison of Allogeneic versus Autologous Stem Cell Transplantation in Transformed Low-Grade Lymphoid Malignancies: A Systematic Review and Pooled Analysis of Comparative Studies.Acta Haematol136, 244-255.
Jourdain, A., Auperin, A., Minard-Colin, V., Aladjidi, N., Zsiros, J., Coze, C., Gandemer, V., Bertrand, Y., Leverger, G., Bergeron, C., et al. (2015). Outcome and Prognostic Factors of relapse in Children and Adolescents with Mature B-Cell Lymphoma and Leukemia treated in 3 consecutive prospective Lymphomes Malins B protocols. Study of the Société Française des Cancers de l'Enfant.Haematologica.
Robin, M., Porcher, R., Wolschke, C., de Fontbrune, F.Sicre, Alchalby, H., Christopeit, M., Cassinat, B., Zabelina, T., de Latour, R.Peffault, Ayuk, F., et al. (2016). Outcome after transplantation according to reduced intensity conditioning regimen in patients transplanted for myelofibrosis.Biol Blood Marrow Transplant.
Comenzo, R.L. (2015). Out, Out - Making Amyloid's Candle Briefer.N Engl J Med373, 1167-1169.
Chen, J.C., and Christiano, A.M. (2016). Out of Many, One: Computational Reconstruction of Mouse Skin using Single-Cell Transcriptomics.Cell Stem Cell19, 421-422.
Kaur, R., Aiken, C., Morrison, L.Coudière, Rao, R., Del Bigio, M.R., Rampalli, S., and Werbowetski-Ogilvie, T. (2015). OTX2 exhibits cell context-dependent effects on cellular and molecular properties of human embryonic neural precursors and medulloblastoma cells.Dis Model Mech.
Yao, Y., Liang, X., Shi, Y., Lin, Y., and Yang, J. (2018). Osthole Delays Tert-Butyl Hydroperoxide-Induced Premature Senescence in Neural Stem Cells.Cell Reprogram.
Khojasteh, A., Dashti, S.Ghazaleh, Dehghan, M.Mehdi, Behnia, H., Abbasnia, P., and Morad, G. (2014). The osteoregenerative effects of platelet-derived growth factor BB cotransplanted with mesenchymal stem cells, loaded on freeze-dried mineral bone block: A pilot study in dog mandible.J Biomed Mater Res B Appl Biomater.
Tong, X., Gu, J., Song, R., Wang, D., Sun, Z., Sui, C., Zhang, C., Liu, X., Bian, J., and Liu, Z. (2018). Osteoprotegerin inhibit osteoclast differentiation and bone resorption by enhancing autophagy via AMPK/mTOR/p70S6K signaling pathway in vitro.J Cell Biochem.
Liu, X., Bao, C., Xu, H.H.K., Pan, J., Hu, J., Wang, P., and Luo, E. (2016). Osteoprotegerin gene-modified BMSCs with hydroxyapatite scaffold for treating critical-sized mandibular defects in ovariectomized osteoporotic rats.Acta Biomater.
Mahapatra, C., Singh, R.Kumar, Kim, J.-J., Patel, K.Dev, Perez, R.A., Jang, J.-H., and Kim, H.-W. (2016). Osteopromoting reservoir of stem cells: Bioactive mesoporous nanocarrier / collagen gel through slow-releasing FGF18 and the activated BMP signaling.Acs Appl Mater Interfaces.
Alam, M., Bertolini, M., Gherardini, J., Keren, A., Ponce, L., Chéret, J., Alenfall, J., Dunér, P., Nilsson, A.H., Gilhar, A., et al. (2019). An osteopontin-derived peptide inhibits human hair growth at least in part by decreasing FGF7 production in outer root sheath keratinocytes.Br J Dermatol.
Weber, C.E., Kothari, A.N., Wai, P.Y., Li, N.Y., Driver, J., Zapf, M.A.C., Franzen, C.A., Gupta, G.N., Osipo, C., Zlobin, A., et al. (2014). Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.Oncogene.
Rao, G., Du, L., and Chen, Q. (2013). Osteopontin, a possible modulator of cancer stem cells and their malignant niche.Oncoimmunology2, e24169.
Kristen, A.V., Rosenberg, M., Lindenmaier, D., Merkle, C., Steen, H., Andre, F., Schönland, S.O., Schnabel, P.A., Schuster, T., Röcken, C., et al. (2014). Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.Amyloid1-9.
Sobacchi, C., Schulz, A., Coxon, F.P., Villa, A., and Helfrich, M.H. (2013). Osteopetrosis: genetics, treatment and new insights into osteoclast function.Nat Rev Endocrinol.